Brief: Ryvu Therapeutics To Issue Up To 4.8 Mln J Series Shares

Ryvu Therapeutics SA

06/10/2022 06:57

Oct 6 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * SAID ON WEDNESDAY THE MANAGEMENT BOARD HAS RESOLVED TO
INCREASE
COMPANY'S SHARE CAPITAL VIA ISSUE OF J SERIES SHARES
    * UNDER RESOLUTION COMPANY TO RISE UP TO 1.9 MLN ZLOTYS VIA
ISSUE
OF UP TO 4.8 MILLION NEW SHARES
    * LOCK-UP AGREEMENTS HAVE BEEN SIGNED BETWEEN CEO PAWEL
PRZEWIEZLIKOWSKI, DEPUTY CEO KRZYSZTOF BRZOZKA AND TRIGON DOM
MAKLERSKI
    * UNDER SAID AGREEMENTS THE AFOREMENTIONED SHAREHOLDERS
OBLIGED TO
RESTRAIN FROM ANY ACTIONS OF DISPOSITION OF SHARES THEY HAD HELD
ON THE DAY OF SIGNING, AS WELL AS ANY NEW SHARES
    * THE BINDING PERIOD FOR SAID AGREEMENT WAS SET AT 12 MONTHS
STARTING FROM THE DAY OF J SERIES SHARES ALLOCATION
    * THE COMPANY ALSO SIGNED A SEPARATE LOCK-UP AGREEMENT WITH
TRIGON
    * UNDER SAID AGREEMENT THE COMPANY OBLIGED NOT TO OFFER OR
ISSUE
SHARES, OR SECURITIES CONVERTIBLE OR INCORPORATING OTHER RIGHT
TO ACQUIRE COMPANY'S SHARES, OR TO CONDUCT ANY ACTIONS OF
DISPOSITION OF SAID SECURITIES WITHOUT TRIGON'S PERMISSION
    * SAID AGREEMENT'S BINDING PERIOD IS ALSO SET AT 12 MONTHS
STARTING ON THE DAY OF J SERIES ALLOCATION

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM9StmYXa
 Further company coverage:  RVU.WA  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))